Archive: 02/11/2016
Some immune-boosting cancer drugs may pose rare heart risks
Doctors have found a disturbing downside to some powerful new drugs that harness the immune system to fight cancer: In rare cases, they may cause potentially fatal heart damage, especially when used together.
Nov 2, 2016
Safety concerns linger for generic oncology drugs in developing countries
Although generic oncology drugs can reduce patient costs and improve treatment access, the safety of these drugs in developing countries is uncertain, according to an international research team led by Dr. Charles Bennett, ...
Nov 2, 2016
Gene mutations may increase adverse event risk in older adults taking multiple meds
Gene mutations that affect drug metabolism may explain higher hospitalization rates for some older adults taking multiple medications, according to researchers from Columbia University.
Nov 2, 2016
Lack of brain shrinkage may help predict who develops dementia with Lewy bodies
Dementia with Lewy bodies is a progressive disease that causes hallucinations, decline in mental abilities, rigid muscles, slow movement and tremors. With symptoms similar to Alzheimer's disease and Parkinson's disease, a ...
Nov 2, 2016
Cempra shares plummet ahead of FDA meeting on antibiotic
Shares of drugmaker Cempra Inc. plunged Wednesday after federal regulators raised concerns about potential liver toxicity risks with its closely watched experimental antibiotic.
Nov 2, 2016
Kids should be part of treatment for moms fighting substance use
Mothers in therapy for drug and alcohol use recover faster if their children take part in their treatment sessions, according to a first-of-its-kind study.
Nov 2, 2016
Alcohol's cancer toll revealed
Alcohol consumption caused more than 700,000 new cancer cases and around 366,000 cancer deaths in 2012, mainly in rich countries, according to data reported Wednesday to the World Cancer Congress in Paris.
Nov 2, 2016